Analysis of carcinogenic risk based on mode of drug action.
Toxicology Research Laboratories Fujisawa Pharmaceutical Co., Ltd.
T
T
Fujii
D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods; D002273:Carcinogens / Q000633:toxicity*; D002276:Carcinoid Tumor / Q000139:chemically induced; D005753:Gastric Mucosa / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D051381:Rats; D018570:Risk Assessment; D013270:Stomach / Q000187:drug effects; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000378:metabolism
D002273:Carcinogens; D005755:Gastrins